Levin W, Michaud D P, Thomas P E, Jerina D M
Arch Biochem Biophys. 1983 Feb 1;220(2):485-94. doi: 10.1016/0003-9861(83)90439-3.
Metabolism of cholesterol 5,6 alpha-oxide to the 5,6-glycol is catalyzed by a rat liver microsomal epoxide hydrolase that is distinct from the microsomal epoxide hydrolase that metabolizes a wide range of xenobiotic alkene and arene oxides. The two enzymes are antigenically distinct, and the purified microsomal epoxide hydrolase that metabolizes xenobiotic oxides does not catalyze the hydration of cholesterol 5,6 alpha-oxide. In vivo treatment of rats with inducers of microsomal epoxide hydrolase does not enhance the activity of cholesterol 5,6 alpha-oxide hydrolase and, in some cases, actually depresses enzyme activity in the resultant microsomal preparations. Octene 1,2-oxide and benz[a]anthracene 5,6-oxide, both good substrates for xenobiotic epoxide hydrolase, are not competitive inhibitors of cholesterol oxide hydration by rat liver microsomes. The above results establish the existence of a liver microsomal epoxide hydrolase that is under different regulatory control and that appears to have a different substrate specificity than the well-characterized microsomal epoxide hydrolase involved in the metabolism of a widely diverse group of alkene and arene oxides.
胆固醇5,6α-氧化物向5,6-二醇的代谢由大鼠肝脏微粒体环氧化物水解酶催化,该酶与代谢多种外源性烯烃和芳烃氧化物的微粒体环氧化物水解酶不同。这两种酶在抗原性上不同,且纯化的代谢外源性氧化物的微粒体环氧化物水解酶不催化胆固醇5,6α-氧化物的水化反应。用微粒体环氧化物水解酶诱导剂对大鼠进行体内处理,不会增强胆固醇5,6α-氧化物水解酶的活性,在某些情况下,实际上还会降低所得微粒体制剂中的酶活性。1,2-环氧辛烷和苯并[a]蒽5,6-氧化物都是外源性环氧化物水解酶的良好底物,但不是大鼠肝脏微粒体催化胆固醇氧化物水化反应的竞争性抑制剂。上述结果证实存在一种肝脏微粒体环氧化物水解酶,它受不同的调控,并且与参与多种烯烃和芳烃氧化物代谢的、特性明确的微粒体环氧化物水解酶相比,似乎具有不同的底物特异性。